Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
Current Gastroenterology Reports|May 18, 2016
Practical Approaches to "Top-Down" Therapies for Crohn's DiseaseAranzazu Jauregui Amezaga, Gert Van Assche
Gut|October 30, 2010
Management of acute severe ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Journal of Crohn'S & Colitis|December 22, 2010
Management of loss of response to anti-TNF drugs: Change the dose or change the drug?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|April 3, 2004
Medical therapy for Crohn's disease stricturesGert Van Assche, Karel Geboes, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
Should family members of IBD patients be screened for CARD15/NOD2 mutations?Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging biological treatments in inflammatory bowel diseasesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Best Practice & Research. Clinical Gastroenterology|March 5, 2009
Serum sickness, encephalitis and other complications of anti-cytokine therapySéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Gastroenterology|March 3, 2009
Biological therapies for inflammatory bowel diseasesPaul Rutgeerts, Severine Vermeire, Gert Van Assche
World Journal of Gastroenterology|June 3, 2010
Role of genetics in prediction of disease course and response to therapySeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Inflammatory Bowel Diseases|October 9, 2004
C-reactive protein as a marker for inflammatory bowel diseaseSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Current Gastroenterology Reports|May 18, 2016
Practical Approaches to "Top-Down" Therapies for Crohn's DiseaseAranzazu Jauregui Amezaga, Gert Van Assche
Gut|October 30, 2010
Management of acute severe ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Journal of Crohn'S & Colitis|December 22, 2010
Management of loss of response to anti-TNF drugs: Change the dose or change the drug?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|April 3, 2004
Medical therapy for Crohn's disease stricturesGert Van Assche, Karel Geboes, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
Should family members of IBD patients be screened for CARD15/NOD2 mutations?Severine Vermeire, Gert Van Assche, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging biological treatments in inflammatory bowel diseasesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Best Practice & Research. Clinical Gastroenterology|March 5, 2009
Serum sickness, encephalitis and other complications of anti-cytokine therapySéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Gastroenterology|March 3, 2009
Biological therapies for inflammatory bowel diseasesPaul Rutgeerts, Severine Vermeire, Gert Van Assche
World Journal of Gastroenterology|June 3, 2010
Role of genetics in prediction of disease course and response to therapySeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Inflammatory Bowel Diseases|October 9, 2004
C-reactive protein as a marker for inflammatory bowel diseaseSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Pageof 29